EpCAM is an important marker for cancer stem cells (CSCs) in the breast, prostate, pancreas, colon and hepatocellular cancers (Kaur et al., 2018; AbdelMageed et al., 2022; Dzobo et al., 2021; Zarębska et al., 2021). Here, EPCAM is linked to cancer.